Intellectual Property India Publishes Patent Application for Folic Acid-Modified Polymeric Nanoparticle Encapsulating Isocorydine For Targeted Triple Negative Breast Cancer Therapy.

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202641082123 A) filed by University Of Kerala on July 03, 2026, for Folic Acid-Modified Polymeric Nanoparticle Encapsulating Isocorydine For Targeted Triple Negative Breast Cancer Therapy..

Inventors include Dr. Janeesh P. A; and Sudhina S.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Title: Folic Acid-Modified Polymeric Nanoparticle Encapsulating Isocorydine for Targeted Triple Negative Breast Cancer Therapy. A nano-carrier system, wherein folic acid ligand is conjugated on the surface of PLGA-PEG nanoparticles encapsulating Isocorydine facilitates folate receptor-mediated endocytosis through ove...